Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues

BACKGROUND: Due to the heterogeneity of cancer, identifying differentially methylated (DM) CpG sites between a set of cancer samples and a set of normal samples cannot tell us which patients have methylation aberrations in a particular DM CpG site. METHODS: We firstly showed that the relative methyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Haidan, Guan, Qingzhou, He, Jun, Lin, Yunqing, Zhang, Juan, Li, Hongdong, Liu, Huaping, Gu, Yunyan, Guo, Zheng, He, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299650/
https://www.ncbi.nlm.nih.gov/pubmed/28178989
http://dx.doi.org/10.1186/s12967-017-1122-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299650/
https://www.ncbi.nlm.nih.gov/pubmed/28178989
http://dx.doi.org/10.1186/s12967-017-1122-y

Ejemplares similares